IV Simpósio Internacional de Imunodeficiência
Preliminary Program
|
November 7th (Thursday)
|
|
| 8:30-8:45 | Opening remarks João Bosco and Alberto Duarte |
| 8:50-9:30 | Opening lecture: The multiple faces of GATA2. Steven Holland, NIH, USA |
| 9:30-9:50 | Selected oral abstract |
| 9:50-10:30 | Educational Session: Diagnosis and Management of Common Variable Immunodeficiency Charlotte Cunningham-Rundles, Mount-Sinai Hospital, USA |
| 10:30-10:50 | Coffe break |
| 10:50-11:30 | State-of-the-art: Understanding B-cell tolerance breakdown Mechanisms in PIDs Eric Meffre, Yale School of Medicine, USA |
| 11:30-12:10 | Educational Session: Diagnosis and Management of HLH Jack Bleesing, Cincinnati Children´s Hospital, USA |
| 12:15-13:15 | Sponsored Lunch (Novartis): Autoinflammatory Syndromes Speaker to be defined |
| 13:15-14:00 | Poster Presentation |
| 14:00- 14:40 | State-of-the-art: XMEN syndrome: a novel human T cell defect Michael Lenardo, NIAID, National Institutes of Health, USA |
| 14:40-15:00 | Seleted oral abstract |
| 15:00-15:40 | Educational Session- Immunodysregulation disorders Troy Torgerson, Seattle Children´s Hospital, USA |
| 15:40-16:00 | Coffe break |
| 16:00-16:40 | State-of-the-art: ALPS and related disorders João Bosco Oliveira, IMIP, Brazil |
| 16:40-18:00 | Practical aspects of PID management: – Vaccination in PID patients – IVIG: uses and abuses |
|
November 8th (Friday)
|
|
| 8:30-9:10 | State-of-the-art: What is new in 22q11deletion syndrome Kathleen Sullivan, Children´s Hospital of Philadelphia |
| 9:10-9:30 | Selected oral abstract |
| 9:30-10:10 | Educational Session: Diagnosis and management of neutropenias Kaan Boztug, Vienna Medical Institute, Austria |
| 10:10-10:30 | Coffe break |
| 10:30-11:10 | State-of-the-art: Thomas Fleisher: Screening for SCID in the US: current status and future prospects |
| 11:10-11:30 | Selected oral abstract |
| 11:30-13:15 | Immunoglobulin Satellite Symposium |
| 13:15-14:00 | Poster presentation and lunch |
| 14:00-14:40 | State-of-the-art: Novel defects causing congenital neutropenia Kaan Boztug, Vienna Medical Institute, Austria |
| 14:40-15:10 | Educational Session: Diagnosis and management of Wiskott-Aldrich Syndrome Troy Torgerson, Seattle Children´s Hospital, USA |
| 15:50-16:10 | Coffe break |
| 16:10-16:50 | Selected oral abstracts |
| 16:50-17:30 | Educational Session: Chronic Granulomatous Disorder Steve Holland, NIAID, National Institutes of Health, USA |
| 17:30-18:30 | Practical aspects of PID management: SCID treatment before BMT |
|
November 9th (Saturday)
|
|
| 8:30-9:10 | State-of-the art session: Novel insights into de pathogenesis of B cell defects Charlotte Cunningham-Rundles, Mount-Sinai Hospital, USA |
| 9:10-9:50 | Selected oral abstracts |
| 9:50-10:30 | Educational Session: BMT for the treatment of PIDs Jack Bleesing, Cincinnati Children´s Hospital, USA |
| 10:30-10:50 | Coffee break |
| 10:50-11:30 | Educational Session: Diagnosis and management of DNA repair defects Kathleen Sullivan, Children´s Hospital of Philadelphia |
| 11:30-12:10 | Closing Session: TBD |
Mais informações através do site www.sidep.org.br